Jay Lichter, Avalon BioVentures CEO

Aval­on Ven­tures spins off a sep­a­rate fund to han­dle life sci­ence com­pa­nies — armed with $135M

Aval­on Ven­tures has been a ma­jor play­er in the in­vest­ing games both in tech and in the biotech world, but now a new fund …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.